Risk Factors for Long-Term Complications and Quality of Life after HCT

Track: BMT Tandem "Scientific" Meeting
Friday, February 28, 2014, 8:30 AM-10:00 AM
Texas B+D (Gaylord Texan)
John R. Wingard, MD , Medicine, University of Florida, Gainesville, FL
Disclosures:
J. R. Wingard, Astellas, consultant in design of vaccine trial: Consultancy
Pfizer, speaker: Honoraria
NERI, Data review committee: Consultancy
UpToDate, writer of articles: Royalty
<< Previous Presentation | Next Presentation